Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Arnon Nagler
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Chemicals & Drugs
Living Beings
Anatomy
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
88
Slavin, Shimon
79
Or, Reuven
59
Naparstek, Elizabeth
34
Shimoni, Avichai
32
Pines, Mark
32
Hardan, Izhar
31
Ackerstein, Aliza
30
Kapelushnik, Joseph
25
Lapidot, Tsvee
23
Varadi, Gabor
20
Rechavi, Gideon
19
Aker, Memet
18
Avigdor, Abraham
18
Brautbar, Chaim
18
Ilan, Yaron
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Arnon Nagler (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Trakhtenbrot Luba; Hardan Izhar; Koren-Michowitz Maya; Oren Shirley; Yshoev Galina; Rechavi Gideon; Nagler Arnon; Amariglio Ninette
Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Genes, chromosomes & cancer 2010;49(1):17-27.
-
2009: Arien-Zakay H; Lecht S; Bercu M M; Amariglio N; Rechavi G; Galski H; Lazarovici P; Nagler A
Interferon-gamma-induced neuronal differentiation of human umbilical cord blood-derived progenitors.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(10):1790-800.
-
2009: Stanevsky Anfisa; Goldstein Gal; Nagler Arnon
Umbilical cord blood transplantation: pros, cons and beyond.
Blood reviews 2009;23(5):199-204.
-
2009: Ostrovsky Olga; Korostishevsky Michael; Shafat Itay; Mayorov Margarita; Ilan Neta; Vlodavsky Israel; Nagler Arnon
Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation.
Journal of leukocyte biology 2009;86(2):445-55.
-
2009: Abraham M; Beider K; Wald H; Weiss I D; Zipori D; Galun E; Nagler A; Eizenberg O; Peled A
The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(8):1378-88.
-
2009: Kröger Nicolaus; Badbaran Anita; Lioznov Michael; Schwarz Sabine; Zeschke Silke; Hildebrand York; Ayuk Francis; Atanackovic Djordje; Schilling Georgia; Zabelina Tatjana; Bacher Ulrike; Klyuchnikov Evgeny; Shimoni Avichai; Nagler Arnon; Corradini Paolo; Fehse Boris; Zander Axel
Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.
Experimental hematology 2009;37(7):791-8.
-
2009: Dezorella Nili; Pevsner-Fischer Meirav; Deutsch Varda; Kay Sigi; Baron Shoshana; Stern Ruth; Tavor Sigal; Nagler Arnon; Naparstek Elizabeth; Zipori Dov; Katz Ben-Zion
Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Experimental cell research 2009;315(11):1904-13.
-
2009: Mohty Mohamad; Rocha Vanderson; Chevallier Patrice; Harousseau Jean-Luc; Nagler Arnon
Reduced-intensity conditioning for allogeneic stem cell transplantation: 10 years later.
Current opinion in oncology 2009;21 Suppl 1():S1.
-
2009: Besser Michal J; Shapira-Frommer Ronnie; Treves Avraham J; Zippel Dov; Itzhaki Orit; Schallmach Ester; Kubi Adva; Shalmon Bruria; Hardan Izhar; Catane Raphael; Segal Eran; Markel Gal; Apter Sara; Nun Alon Ben; Kuchuk Iryna; Shimoni Avichai; Nagler Arnon; Schachter Jacob
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(4):415-23.
-
2009: Baccarani Michele; Rosti Gianantonio; Castagnetti Fausto; Haznedaroglu Ibrahim; Porkka Kimmo; Abruzzese Elisabetta; Alimena Giuliana; Ehrencrona Hans; Hjorth-Hansen Henrik; Kairisto Veli; Levato Luciano; Martinelli Giovanni; Nagler Arnon; Lanng Nielsen Johan; Ozbek Ugur; Palandri Francesca; Palmieri Fausto; Pane Fabrizio; Rege-Cambrin Giovanna; Russo Domenico; Specchia Giorgina; Testoni Nicoletta; Weiss-Bjerrum Ole; Saglio Giuseppe; Simonsson Bengt
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
Blood 2009;113(19):4497-504.
-
2009: Zion Orit; Genin Olga; Kawada Norifumi; Yoshizato Katsutoshi; Roffe Suzy; Nagler Arnon; Iovanna Juan L; Halevy Orna; Pines Mark
Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
Pancreas 2009;38(4):427-35.
-
2009: Vagima Yaron; Avigdor Abraham; Goichberg Polina; Shivtiel Shoham; Tesio Melania; Kalinkovich Alexander; Golan Karin; Dar Ayelet; Kollet Orit; Petit Isabelle; Perl Orly; Rosenthal Ester; Resnick Igor; Hardan Izhar; Gellman Yechiel N; Naor David; Nagler Arnon; Lapidot Tsvee
MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization.
The Journal of clinical investigation 2009;119(3):492-503.
-
2009: Arien-Zakay Hadar; Lecht Shimon; Bercu Marian M; Tabakman Rinat; Kohen Ron; Galski Hanan; Nagler Arnon; Lazarovici Philip
Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors.
Experimental neurology 2009;216(1):83-94.
-
2009: Nagler Arnon
Recent developments in human umbilical cord blood transplantation in Israel.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1 Suppl):99-103.
-
2009: Gisselbrecht Christian; Vose Julie; Nademanee Auayporn; Gianni Alessandro M; Nagler Arnon
Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.
The oncologist 2009;14 Suppl 2():41-51.
-
2009: Markel Gal; Seidman Rachel; Besser Michal J; Zabari Naama; Ortenberg Rona; Shapira Ronnie; Treves Avraham J; Loewenthal Ron; Orenstein Arie; Nagler Arnon; Schachter Jacob
Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.
PloS one 2009;4(5):e5597.
-
2009: Natan Dity; Nagler Arnon; Arav Amir
Freeze-drying of mononuclear cells derived from umbilical cord blood followed by colony formation.
PloS one 2009;4(4):e5240.
-
2009: Beider Katia; Abraham Michal; Begin Michal; Wald Hanna; Weiss Ido D; Wald Ori; Pikarsky Eli; Abramovitch Rinat; Zeira Evelyne; Galun Eithan; Nagler Arnon; Peled Amnon
Interaction between CXCR4 and CCL20 pathways regulates tumor growth.
PloS one 2009;4(4):e5125.
-
2008: Bladé Joan; Sonneveld Pieter; San Miguel Jesús F; Sutherland Heather J; Hajek Roman; Nagler Arnon; Spencer Andrew; Robak Tadeusz; Cibeira M Teresa; Zhuang Sen H; Harousseau Jean-Luc; Orlowski Robert Z;
Pegylated liposomal doxorubicin plus bortezomib in relapsed or refractory multiple myeloma: efficacy and safety in patients with renal function impairment.
Clinical lymphoma & myeloma 2008;8(6):352-5.
-
2008: Turgeman Tidhar; Hagai Yosey; Huebner Kyla; Jassal Davinder S; Anderson Judy E; Genin Olga; Nagler Arnon; Halevy Orna; Pines Mark
Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.
Neuromuscular disorders : NMD 2008;18(11):857-68.
-
2008: Ciceri Fabio; Labopin Myriam; Aversa Franco; Rowe Jakob M; Bunjes Donald; Lewalle Philippe; Nagler Arnon; Di Bartolomeo Paolo; Lacerda João F; Lupo Stanghellini Maria Teresa; Polge Emmanuelle; Frassoni Francesco; Martelli Massimo F; Rocha Vanderson;
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation.
Blood 2008;112(9):3574-81.
-
2008: Hartmann Tanja Nicole; Grabovsky Valentin; Pasvolsky Ronit; Shulman Ziv; Buss Eike C; Spiegel Asaf; Nagler Arnon; Lapidot Tsvee; Thelen Marcus; Alon Ronen
A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells.
Journal of leukocyte biology 2008;84(4):1130-40.
-
2008: Simanovsky Masha; Berlinsky Sagi; Sinai Pirchia; Leiba Merav; Nagler Arnon; Galski Hanan
Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia.
Differentiation; research in biological diversity 2008;76(8):908-22.
-
2008: Genin Olga; Rechavi Gideon; Nagler Arnon; Ben-Itzhak Ofer; Nazemi Kellie J; Pines Mark
Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?
Neoplasia (New York, N.Y.) 2008;10(9):940-8.
-
2008: Ayuk Francis; Perez-Simon José A; Shimoni Avichai; Sureda Anna; Zabelina Tatjana; Schwerdtfeger Rainer; Martino Rodrigo; Sayer Herbert Gottfried; Alegre Adrián; Lahuerta Juan-José; Atanackovic Djordje; Wolschke Christine; Nagler Arnon; Zander Axel R; San Miguel Jesús F; Kröger Nicolaus
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Haematologica 2008;93(9):1343-50.
-
2008: Schallmach Ester; Sareli Rina; Besser Michal J; Leipsiger Shai; Hardan Izhar; Treves Avraham J; Nagler Arnon; Schachter Jacob
Collection of large-scale expanded lymphocyte cultures for adoptive immunotherapy using a COBE Spectra apheresis machine.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(6):563-8.
-
2008: Schilling G; Hansen T; Shimoni A; Zabelina T; Pérez-Simón J-A; Gutierrez N C; Bethge W; Liebisch P; Schwerdtfeger R; Bornhäuser M; Otterstetter S; Penas E M M; Dierlamm J; Ayuk F; Atanackovic D; Bacher U; Bokemeyer C; Zander A; San Miguel J; Nagler A; Kröger N
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(6):1250-5.
-
2008: Berger Raanan; Rotem-Yehudar Rinat; Slama Gideon; Landes Shimon; Kneller Abraham; Leiba Merav; Koren-Michowitz Maya; Shimoni Avichai; Nagler Arnon
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(10):3044-51.
-
2008: Meirow Dror; Hardan Izhar; Dor Jehoshua; Fridman Eduard; Elizur Shai; Ra'anani Hila; Slyusarevsky Elena; Amariglio Ninette; Schiff Eyal; Rechavi Gideon; Nagler Arnon; Ben Yehuda Dina
Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.
Human reproduction (Oxford, England) 2008;23(5):1007-13.
-
2008: Spiegel Asaf; Zcharia Eyal; Vagima Yaron; Itkin Tomer; Kalinkovich Alexander; Dar Ayelet; Kollet Orit; Netzer Neta; Golan Karin; Shafat Itay; Ilan Neta; Nagler Arnon; Vlodavsky Israel; Lapidot Tsvee
Heparanase regulates retention and proliferation of primitive Sca-1+/c-Kit+/Lin- cells via modulation of the bone marrow microenvironment.
Blood 2008;111(10):4934-43.
-
2008: Sonneveld Pieter; Hajek Roman; Nagler Arnon; Spencer Andrew; Bladé Joan; Robak Tadeusz; Zhuang Sen H; Harousseau Jean-Luc; Orlowski Robert Z;
Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.
Cancer 2008;112(7):1529-37.
-
2008: El-Cheikh Jean; Michallet Mauricette; Nagler Arnon; de Lavallade Hugues; Nicolini Franck E; Shimoni Avichai; Faucher Catherine; Sobh Mohamad; Revesz Daniela; Hardan Izhar; Fürst Sabine; Blaise Didier; Mohty Mohamad
High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma.
Haematologica 2008;93(3):455-8.
-
2008: Koren-Michowitz Maya; Shimoni Avichai; Vivante Asaf; Trakhtenbrot Luba; Rechavi Gideon; Amariglio Ninette; Loewenthal Ron; Nagler Arnon; Cohen Yoram
A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).
Leukemia research 2008;32(3):421-7.
-
2008: Mohty Mohamad; Labopin Myriam; Tabrizzi Reza; Theorin Niklas; Fauser Axel A; Rambaldi Alessandro; Maertens Johan; Slavin Shimon; Majolino Ignazio; Nagler Arnon; Blaise Didier; Rocha Vanderson;
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.
Haematologica 2008;93(2):303-6.
-
2008: Shimoni A; Zwas S T; Oksman Y; Hardan I; Shem-Tov N; Rand A; Yerushalmi R; Avigdor A; Ben-Bassat I; Nagler A
Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.
Bone marrow transplantation 2008;41(4):355-61.
-
2008: Natkunam Yasodha; Farinha Pedro; Hsi Eric D; Hans Christine P; Tibshirani Robert; Sehn Laurie H; Connors Joseph M; Gratzinger Dita; Rosado Manuel; Zhao Shuchun; Pohlman Brad; Wongchaowart Nicholas; Bast Martin; Avigdor Abraham; Schiby Ginette; Nagler Arnon; Byrne Gerald E; Levy Ronald; Gascoyne Randy D; Lossos Izidore S
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):447-54.
-
2008: Gratzinger Dita; Zhao Shuchun; Tibshirani Robert J; Hsi Eric D; Hans Christine P; Pohlman Brad; Bast Martin; Avigdor Abraham; Schiby Ginette; Nagler Arnon; Byrne Gerald E; Lossos Izidore S; Natkunam Yasodha
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.
Laboratory investigation; a journal of technical methods and pathology 2008;88(1):38-47.
-
2008: Ashur-Fabian O; Trakhtenbrot L; Dominissini D; Koren-Michowitz M; Nagler A; Rechavi G; Amariglio N
The presence of a single PML-RARA isoform lacking exon 5 in FISH-negative APL samples.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(1):200-3.
-
2008: Ruvinov Emil; Sharabani-Yosef Orna; Nagler Arnon; Einbinder Tom; Feinberg Micha S; Holbova Radka; Douvdevani Amos; Leor Jonathan
Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium.
Fibrogenesis & tissue repair 2008;1(1):7.
-
2008: Barsheshet Alon; Hod Hanoch; Shechter Michael; Sharabani-Yosef Orna; Rosenthal Eti; Barbash Israel M; Matetzky Shlomi; Tal Reshef; Bentancur Ariel G; Sela Ben-Ami; Nagler Arnon; Leor Jonathan
The effects of external counter pulsation therapy on circulating endothelial progenitor cells in patients with angina pectoris.
Cardiology 2008;110(3):160-6.
-
2007: Shimoni Avichai; Hardan Izhar; Shem-Tov Noga; Rand Avital; Yerushalmi Ronit; Nagler Arnon
Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes.
Leukemia & lymphoma 2007;48(12):2352-9.
-
2007: Schmid Christoph; Labopin Myriam; Nagler Arnon; Bornhäuser Martin; Finke Jürgen; Fassas Athanasios; Volin Liisa; Gürman Günham; Maertens Johan; Bordigoni Pierre; Holler Ernst; Ehninger Gerhard; Polge Emmanuelle; Gorin Norbert-Claude; Kolb Hans-Jochem; Rocha Vanderson;
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4938-45.
-
2007: Shimoni Avichai; Nagler Arnon
Radioimmunotherapy and stem-cell transplantation in the treatment of aggressive B-cell lymphoma.
Leukemia & lymphoma 2007;48(11):2110-20.
-
2007: Ostrovsky O; Korostishevsky M; Levite I; Leiba M; Galski H; Vlodavsky I; Nagler A
Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(11):2296-303.
-
2007: Spiegel Asaf; Shivtiel Shoham; Kalinkovich Alexander; Ludin Aya; Netzer Neta; Goichberg Polina; Azaria Yaara; Resnick Igor; Hardan Izhar; Ben-Hur Herzel; Nagler Arnon; Rubinstein Menachem; Lapidot Tsvee
Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling.
Nature immunology 2007;8(10):1123-31.
-
2007: Shimoni A; Hardan I; Shem-Tov N; Rand A; Herscovici C; Yerushalmi R; Nagler A
Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(10):2109-16.
-
2007: Koren-Michowitz Maya; Hardan Izhar; Berghoff Janina; Yshoev Galina; Amariglio Ninette; Rechavi Gideon; Nagler Arnon; Trakhtenbrot Luba
Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis.
Cancer letters 2007;255(2):307-14.
-
2007: Ashur-Fabian Osnat; Amariglio Ninette; Cohen Yoram; Nagler Arnon; Rechavi Gideon; Salomon Ophira
The disappearance of two alleles of JAK2 V617F from peripheral blood of a polycythaemia vera patient correlates with transformation into myelofibrosis.
British journal of haematology 2007;138(6):822-3.
-
2007: Orlowski Robert Z; Nagler Arnon; Sonneveld Pieter; Bladé Joan; Hajek Roman; Spencer Andrew; San Miguel Jesús; Robak Tadeusz; Dmoszynska Anna; Horvath Noemi; Spicka Ivan; Sutherland Heather J; Suvorov Alexander N; Zhuang Sen H; Parekh Trilok; Xiu Liang; Yuan Zhilong; Rackoff Wayne; Harousseau Jean-Luc
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3892-901.
-
2007: Abraham Michal; Biyder Katia; Begin Michal; Wald Hanna; Weiss Ido D; Galun Eithan; Nagler Arnon; Peled Amnon
Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.
Stem cells (Dayton, Ohio) 2007;25(9):2158-66.
-
2007: Meirow Dror; Baum Micha; Yaron Rabinovici; Levron Jacob; Hardan Izhar; Schiff Eyal; Nagler Arnon; Yehuda Dina Ben; Raanani Hila; Hourvitz Ariel; Dor Jehoshua
Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience.
Leukemia & lymphoma 2007;48(8):1569-76.
-
2007: Shimoni Avichai; Zwas S Tzila; Oksman Yakov; Hardan Izhar; Shem-Tov Noga; Yerushalmi Ronit; Avigdor Abraham; Ben-Bassat Isaac; Nagler Arnon
Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma.
Experimental hematology 2007;35(4):534-40.
-
2007: Gnainsky Y; Kushnirsky Z; Bilu G; Hagai Y; Genina O; Volpin H; Bruck R; Spira G; Nagler A; Kawada N; Yoshizato K; Reinhardt D P; Libermann T A; Pines M
Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.
Cell and tissue research 2007;328(1):153-66.
-
2007: Ashur-Fabian Osnat; Adamsky Konstantin; Trakhtenbrot Luba; Cohen Yoram; Raanani Pia; Hardan Izhar; Nagler Arnon; Rechavi Gideon; Amariglio Ninette
Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisis.
Cell cycle (Georgetown, Tex.) 2007;6(5):589-94.
-
2007: Ilan Yaron; Ohana Meir; Pappo Orit; Margalit Maya; Lalazar Gadi; Engelhardt Dean; Rabbani Elazar; Nagler Arnon
Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
Transplantation 2007;83(4):458-67.
-
2007: Sheffer Yuval; Leon Oded; Pinthus Jehonathan H; Nagler Arnon; Mor Yoram; Genin Olga; Iluz Maya; Kawada Norifumi; Yoshizato Katsutoshi; Pines Mark
Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect.
Molecular cancer therapeutics 2007;6(2):570-7.
-
2007: Arien-Zakay Hadar; Nagler Arnon; Galski Hanan; Lazarovici Philip
Neuronal conditioning medium and nerve growth factor induce neuronal differentiation of collagen-adherent progenitors derived from human umbilical cord blood.
Journal of molecular neuroscience : MN 2007;32(3):179-91.
-
2007: Nagler Arnon; Ohana Meir; Leiba Merav; Levdansky Lilia; Gorodetsky Raphael
Effect of halofuginone, a collagen alpha1(I) inhibitor, on wound healing in normal and irradiated skin: implication for hematopoietic stem cell transplantation.
Acta haematologica 2007;118(2):77-83.
-
2007: Goldstein Gal; Toren Amos; Nagler Arnon
Transplantation and other uses of human umbilical cord blood and stem cells.
Current pharmaceutical design 2007;13(13):1363-73.
-
2007: Amariglio Ninette; Jacob-Hirsch Jasmine; Shimoni Avichai; Leiba Merav; Rechavi Gideon; Nagler Arnon
Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors.
Acta haematologica 2007;117(2):68-73.
-
2007: Ostrovsky Olga; Korostishevsky Michael; Levite Iris; Leiba Merav; Galski Hanan; Gazit Ephraim; Vlodavsky Israel; Nagler Arnon
Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel.
Acta haematologica 2007;117(1):57-64.
-
2006: Gal H; Amariglio N; Trakhtenbrot L; Jacob-Hirsh J; Margalit O; Avigdor A; Nagler A; Tavor S; Ein-Dor L; Lapidot T; Domany E; Rechavi G; Givol D
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(12):2147-54.
-
2006: Kalinkovich Alexander; Tavor Sigal; Avigdor Abraham; Kahn Joy; Brill Alexander; Petit Isabelle; Goichberg Polina; Tesio Melania; Netzer Neta; Naparstek Elizabeth; Hardan Izhar; Nagler Arnon; Resnick Igor; Tsimanis Alexander; Lapidot Tsvee
Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells.
Cancer research 2006;66(22):11013-20.
-
2006: Galski Hanan; Sivan Hamutal; Lazarovici Philip; Nagler Arnon
In vitro and in vivo reversal of MDR1-mediated multidrug resistance by KT-5720: implications on hematological malignancies.
Leukemia research 2006;30(9):1151-8.
-
2006: Gorin Norbert-Claude; Labopin Myriam; Boiron Jean-Michel; Theorin Niklas; Littlewood Tim; Slavin Shimon; Greinix Hildegard; Cahn Jean Yves; Alessandrino E Paolo; Rambaldi Alessandro; Nagler Arnon; Polge Emmanuelle; Rocha Vanderson;
Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3959-66.
-
2006: Leiba M; Cahalon L; Shimoni A; Lider O; Zanin-Zhorov A; Hecht I; Sela U; Vlodavsky I; Nagler A
Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.
Journal of leukocyte biology 2006;80(2):399-406.
-
2006: van de Donk N W C J; Kröger N; Hegenbart U; Corradini P; San Miguel J F; Goldschmidt H; Perez-Simon J A; Zijlmans M; Raymakers R A; Montefusco V; Ayuk F A; van Oers M H J; Nagler A; Verdonck L F; Lokhorst H M
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2006;37(12):1135-41.
-
2006: Gnainsky Yulia; Spira Gadi; Paizi Melia; Bruck Raffael; Nagler Arnon; Genina Olga; Taub Rebbeca; Halevy Orna; Pines Mark
Involvement of the tyrosine phosphatase early gene of liver regeneration (PRL-1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone.
Cell and tissue research 2006;324(3):385-94.
-
2006: Eliashar Ron; Ochana Meir; Maly Bella; Pines Mark; Sichel Jean-Yves; Nagler Arnon
Halofuginone prevents subglottic stenosis in a canine model.
The Annals of otology, rhinology, and laryngology 2006;115(5):382-6.
-
2006: Dekel Benjamin; Shezen Elias; Even-Tov-Friedman Smadar; Katchman Helena; Margalit Raanan; Nagler Arnon; Reisner Yair
Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis.
Stem cells (Dayton, Ohio) 2006;24(5):1185-93.
-
2006: Dagan-Berger Michal; Feniger-Barish Rotem; Avniel Shani; Wald Hanna; Galun Eithan; Grabovsky Valentin; Alon Ronen; Nagler Arnon; Ben-Baruch Adit; Peled Amnon
Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11.
Blood 2006;107(10):3821-31.
-
2006: Nagler Rafael; Barness-Hadar Liat; Lieba Merav; Nagler Arnon
Salivary antioxidant capacity in graft versus host disease.
Cancer investigation 2006;24(3):269-77.
-
2006: van de Donk Niels W C J; Kröger Nicolaus; Hegenbart Ute; Corradini Paolo; San Miguel Jesus F; Goldschmidt Hartmut; Perez-Simon Jose A; Zijlmans Mark; Raymakers Reinier A; Montefusco Vittorio; Ayuk Francis A; van Oers Marinus H J; Nagler Arnon; Verdonck Leo F; Lokhorst Henk M
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Blood 2006;107(8):3415-6.
-
2006: Wald Ori; Weiss Ido D; Wald Hanna; Shoham Hadas; Bar-Shavit Yochay; Beider Katia; Galun Eithan; Weiss Lola; Flaishon Liat; Shachar Idit; Nagler Arnon; Lu Bao; Gerard Craig; Gao Ji-Liang; Mishani Eyal; Farber Joshua; Peled Amnon
IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(8):4716-29.
-
2006: Deininger Michael; Schleuning Michael; Greinix Hilde; Sayer Herbert Gottfried; Fischer Thomas; Martinez Jesus; Maziarz Richard; Olavarria Eduardo; Verdonck Leo; Schaefer Kerstin; Boqué Conxa; Faber Edgar; Nagler Arnon; Pogliani Enrico; Russell Nigel; Volin Liisa; Schanz Urs; Doelken Gottfried; Kiehl Michael; Fauser Axel; Druker Brian; Sureda Anna; Iacobelli Simona; Brand Ronald; Krahl Rainer; Lange Thoralf; Hochhaus Andreas; Gratwohl Alois; Kolb Hans; Niederwieser Dietger;
The effect of prior exposure to imatinib on transplant-related mortality.
Haematologica 2006;91(4):452-9.
-
2006: Pulsipher Michael A; Nagler Arnon; Iannone Robert; Nelson Robert M
Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
Pediatric blood & cancer 2006;46(4):422-33.
-
2006: Bar-Natan Michal; Nagler Arnon
Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
The Israel Medical Association journal : IMAJ 2006;8(3):205-7.
-
2006: Besser Michal J; Treves Avraham J; Itzhaki Orit; Hardan Izhar; Nagler Arnon; Papa Moshe Z; Catane Raphael; Winkler Eyal; Shalmon-Zifroni Bruria; Schachter Jacob
Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical Center.
The Israel Medical Association journal : IMAJ 2006;8(3):164-8.
-
2006: Leor Jonathan; Guetta Esther; Feinberg Micha S; Galski Hanan; Bar Iris; Holbova Radka; Miller Liron; Zarin Parvin; Castel David; Barbash Israel M; Nagler Arnon
Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium.
Stem cells (Dayton, Ohio) 2006;24(3):772-80.
-
2006: Kröger N; Shimoni A; Zabelina T; Schieder H; Panse J; Ayuk F; Wolschke C; Renges H; Dahlke J; Atanackovic D; Nagler A; Zander A
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).
Bone marrow transplantation 2006;37(4):339-44.
-
2006: Shimoni A; Hardan I; Shem-Tov N; Yeshurun M; Yerushalmi R; Avigdor A; Ben-Bassat I; Nagler A
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(2):322-8.
-
2006: Goichberg Polina; Kalinkovich Alexander; Borodovsky Nataliya; Tesio Melania; Petit Isabelle; Nagler Arnon; Hardan Izhar; Lapidot Tsvee
cAMP-induced PKCzeta activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors.
Blood 2006;107(3):870-9.
-
2006: Goldstein Gal; Toren Amos; Nagler Arnon
Human umbilical cord blood biology, transplantation and plasticity.
Current medicinal chemistry 2006;13(11):1249-59.
-
2005: Aoudjhane M; Labopin M; Gorin N C; Shimoni A; Ruutu T; Kolb H-J; Frassoni F; Boiron J M; Yin J L; Finke J; Shouten H; Blaise D; Falda M; Fauser A A; Esteve J; Polge E; Slavin S; Niederwieser D; Nagler A; Rocha V;
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(12):2304-12.
-
2005: Crawley Charles; Szydlo Richard; Lalancette Marc; Bacigalupo Andrea; Lange Andrzej; Brune Mats; Juliusson Gunnar; Nagler Arnon; Gratwohl Alois; Passweg Jakob; Komarnicki Mieczyslaw; Vitek Antonin; Mayer Jiri; Zander Axel; Sierra Jorge; Rambaldi Alessandro; Ringden Olle; Niederwieser Dietger; Apperley Jane F;
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.
Blood 2005;106(9):2969-76.
-
2005: Lahav Meir; Uziel Orit; Kestenbaum Meir; Fraser Abigail; Shapiro Hava; Radnay Judith; Szyper-Kravitz Martine; Avihai Shimoni; Hardan Izhar; Shem-Tov Noga; Nagler Arnon
Nonmyeloablative conditioning does not prevent telomere shortening after allogeneic stem cell transplantation.
Transplantation 2005;80(7):969-76.
-
2005: Peled Toni; Glukhman Elina; Hasson Nira; Adi Sophie; Assor Harel; Yudin Dima; Landor Chana; Mandel Julie; Landau Efrat; Prus Eugenia; Nagler Arnon; Fibach Eitan
Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells.
Experimental hematology 2005;33(10):1092-100.
-
2005: Dar Ayelet; Goichberg Polina; Shinder Vera; Kalinkovich Alexander; Kollet Orit; Netzer Neta; Margalit Raanan; Zsak Marion; Nagler Arnon; Hardan Izhar; Resnick Igor; Rot Antal; Lapidot Tsvee
Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells.
Nature immunology 2005;6(10):1038-46.
-
2005: Pinthus Jehonathan H; Sheffer Yuval; Nagler Arnon; Fridman Eduard; Mor Yoram; Genina Olga; Pines Mark
Inhibition of Wilms tumor xenograft progression by halofuginone is accompanied by activation of WT-1 gene expression.
The Journal of urology 2005;174(4 Pt 2):1527-31.
-
2005: Arbell Dan; Udassin Raphael; Koplewitz Benjamin Z; Ohana Meir; Genina Olga; Pines Mark; Nagler Arnon
Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis.
The Laryngoscope 2005;115(9):1632-5.
-
2005: Tavor Sigal; Petit Isabelle; Porozov Svetlana; Goichberg Polina; Avigdor Abraham; Sagiv Sari; Nagler Arnon; Naparstek Elizabeth; Lapidot Tsvee
Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice.
Blood 2005;106(6):2120-7.
-
2005: Kröger Nicolaus; Shaw Bronwen; Iacobelli Simona; Zabelina Tatjana; Peggs Karl; Shimoni Avichai; Nagler Arnon; Binder Thomas; Eiermann Thomas; Madrigal Alejandro; Schwerdtfeger Rainer; Kiehl Michael; Sayer Herbert Gottfried; Beyer Jörg; Bornhäuser Martin; Ayuk Francis; Zander Axel Rolf; Marks David I;
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.
British journal of haematology 2005;129(5):631-43.
-
2005: De Santis D; Bishara A; Witt C S; Nagler A; Brautbar C; Slavin S; Christiansen F T
Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants.
Tissue antigens 2005;65(6):519-28.
-
2005: Crawley Charles; Lalancette Marc; Szydlo Richard; Gilleece Maria; Peggs Karl; Mackinnon Stephen; Juliusson Gunnar; Ahlberg Lucia; Nagler Arnon; Shimoni Avichai; Sureda Anna; Boiron Jean-Michel; Einsele Herman; Chopra Rajesh; Carella Angelo; Cavenagh Jamie; Gratwohl Alois; Garban Frederic; Zander Axel; Björkstrand Bo; Niederwieser Dietger; Gahrton Gösta; Apperley Jane F;
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.
Blood 2005;105(11):4532-9.
-
2005: Schmitz Norbert; Beksac Meral; Bacigalupo Andrea; Ruutu Tapani; Nagler Arnon; Gluckman Eliane; Russell Nigel; Apperley Jane; Szerm Jeff; Bradstock Kenneth; Buzyn Agnes; Schlegelberger Brigitte; Matcham James; Gratwohl Alois
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
Haematologica 2005;90(5):643-8.
-
2005: Menachem Yoram; Trop Shivti; Kolker Olga; Shibolet Oren; Alper Ruslana; Nagler Arnon; Ilan Yaron
Adoptive transfer of NK 1.1+ lymphocytes in immune-mediated colitis: a pro-inflammatory or a tolerizing subgroup of cells?
Microbes and infection / Institut Pasteur 2005;7(5-6):825-35.
-
2005: Kneller Abraham; Cohen Ninette; Berkowicz Miriam; Reichart Malka; Rosner Esther; Sokolovski Maya; Nagler Arnon; Rechavi Gideon; Amariglio Ninette; Trakhtenbrot Luba
Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease.
Cancer genetics and cytogenetics 2005;159(1):58-62.
-
2005: Findling-Kagan Sarah; Sivan Hamutal; Ostrovsky Olga; Nagler Arnon; Galski Hanan
Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1.
Leukemia research 2005;29(4):407-14.
-
2005: Arditti Fabian D; Aviner Shraga; Dekel Benjamin; Krauthgamer Rita; Gan Judith; Nagler Arnon; Tabilio Antonio; Martelli Massimo; Berrebi Alain; Reisner Yair
Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs.
Blood 2005;105(8):3365-71.
-
2005: Ilan Yaron; Margalit Maya; Ohana Meir; Gotsman Israel; Rabbani Elazar; Engelhardt Dean; Nagler Arnon
Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
Human immunology 2005;66(3):231-40.
-
2005: Gur Hilit; Krauthgamer Rita; Bachar-Lustig Esther; Katchman Helena; Arbel-Goren Rinat; Berrebi Alain; Klein Tirza; Nagler Arnon; Tabilio Antonio; Martelli Massimo F; Reisner Yair
Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha.
Blood 2005;105(6):2585-93.
-
2005: Petit Isabelle; Goichberg Polina; Spiegel Asaf; Peled Amnon; Brodie Chaya; Seger Rony; Nagler Arnon; Alon Ronen; Lapidot Tsvee
Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells.
The Journal of clinical investigation 2005;115(1):168-76.
-
2005: Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A
Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
Bone marrow transplantation 2005;35(2):191-7.
-
2005: Shimoni A; Kröger N; Zabelina T; Ayuk F; Hardan I; Yeshurun M; Shem-Tov N; Avigdor A; Ben-Bassat I; Zander A R; Nagler A
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(1):7-12.
-
2005: Leor J; Guetta E; Chouraqui P; Guetta V; Nagler A
Human umbilical cord blood cells: a new alternative for myocardial repair?
Cytotherapy 2005;7(3):251-7.
-
2005: Raanani Pia; Trakhtenbrot Luba; Rechavi Gideon; Rosenthal Esther; Avigdor Abraham; Brok-Simoni Frida; Leiba Merav; Amariglio Ninette; Nagler Arnon; Ben-Bassat Isaac
Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
Acta haematologica 2005;113(3):181-9.
-
2004: Garbuzenko Ekaterina; Berkman Neville; Puxeddu Ilaria; Kramer Mordechai; Nagler Arnon; Levi-Schaffer Francesca
Mast cells induce activation of human lung fibroblasts in vitro.
Experimental lung research 2004;30(8):705-21.
-
2004: Ostrovsky Olga; Nagler Arnon; Korostishevsky Michael; Gazit Ephraim; Galski Hanan
Genotype and allele frequencies of C3435T polymorphism of the MDR1 gene in various Jewish populations of Israel.
Therapeutic drug monitoring 2004;26(6):679-84.
-
2004: Bielorai Bella; Hughes Mark R; Auerbach Arleen D; Nagler Arnon; Loewenthal Ron; Rechavi Gideon; Toren Amos
Successful umbilical cord blood transplantation for Fanconi anemia using preimplantation genetic diagnosis for HLA-matched donor.
American journal of hematology 2004;77(4):397-9.
-
2004: Kröger Nicolaus; Shimoni Avichai; Zagrivnaja Maria; Ayuk Francis; Lioznov Michael; Schieder Heike; Renges Helmut; Fehse Boris; Zabelina Tatjana; Nagler Arnon; Zander Axel R
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.
Blood 2004;104(10):3361-3.
-
2004: Kröger Nicolaus; Perez-Simon Jose A; Myint Han; Klingemann Hans; Shimoni Avichai; Nagler Arnon; Martino Rodrigo; Alegre Adrian; Tomas Jose F; Schwerdtfeger Rainer; Kiehl Michael; Fauser Axel; Sayer Herbert Gottfried; Leon Angel; Beyer Jörg; Zabelina Tatjana; Ayuk Francis; San Miguel Jesus F; Brand Ronald; Zander Axel Rolf
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):698-708.
-
2004: Raanani Pia; Ben-Bassat Isaac; Gan Shlomit; Trakhtenbrot Luba; Mark Ziva; Ashur-Fabian Osnat; Itskovich Svetlana; Brok-Simoni Frida; Rechavi Gideon; Amariglio Ninette; Nagler Arnon
Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods.
European journal of haematology 2004;73(4):243-50.
-
2004: Abramovitch Rinat; Itzik Anna; Harel Hila; Nagler Arnon; Vlodavsky Israel; Siegal Tali
Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study.
Neoplasia (New York, N.Y.) 2004;6(5):480-9.
-
2004: Cohen Yossi; Nagler Arnon
Umbilical cord blood transplantation--how, when and for whom?
Blood reviews 2004;18(3):167-79.
-
2004: Shimoni Avichai; Nagler Arnon
Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience.
Current hematology reports 2004;3(4):242-8.
-
2004: Shimoni Avichai; Yeshurun Moshe; Hardan Izhar; Avigdor Abraham; Ben-Bassat Isaac; Nagler Arnon
Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(7):484-93.
-
2004: Peled Toni; Landau Efrat; Mandel Julie; Glukhman Elina; Goudsmid Noga R; Nagler Arnon; Fibach Eitan
Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice.
Experimental hematology 2004;32(6):547-55.
-
2004: Nagler A; Ohana M; Shibolet O; Shapira M Y; Alper R; Vlodavsky I; Pines M; Ilan Y
Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone.
European journal of cancer (Oxford, England : 1990) 2004;40(9):1397-403.
-
2004: Kröger Nicolaus; Schilling Georgia; Einsele Hermann; Liebisch Peter; Shimoni Avichai; Nagler Arnon; Perez-Simon Jose A; San Miguel Jesus F; Kiehl Michael; Fauser Axel; Schwerdtfeger Rainer; Wandt Hannes; Sayer Herbert G; Myint Han; Klingemann Hans; Zabelina Tatjana; Dierlamm Judith; Hinke Axel; Zander Axel R
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.
Blood 2004;103(11):4056-61.
-
2004: Franitza Suzanna; Grabovsky Valentin; Wald Ori; Weiss Ido; Beider Katia; Dagan Michal; Darash-Yahana Merav; Nagler Arnon; Brocke Stefan; Galun Eithan; Alon Ronen; Peled Amnon
Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cells.
European journal of immunology 2004;34(5):1333-41.
-
2004: Tavor Sigal; Petit Isabelle; Porozov Svetlana; Avigdor Abraham; Dar Ayelet; Leider-Trejo Leonor; Shemtov Noga; Deutsch Varda; Naparstek Ella; Nagler Arnon; Lapidot Tsvee
CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.
Cancer research 2004;64(8):2817-24.
-
2004: Avigdor Abraham; Goichberg Polina; Shivtiel Shoham; Dar Ayelet; Peled Amnon; Samira Sarit; Kollet Orit; Hershkoviz Rami; Alon Ronen; Hardan Izhar; Ben-Hur Herzl; Naor David; Nagler Arnon; Lapidot Tsvee
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow.
Blood 2004;103(8):2981-9.
-
2004: Kahn Joy; Byk Tamara; Jansson-Sjostrand Lottie; Petit Isabelle; Shivtiel Shoham; Nagler Arnon; Hardan Izhar; Deutsch Varda; Gazit Zulma; Gazit Dan; Karlsson Stefan; Lapidot Tsvee
Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation.
Blood 2004;103(8):2942-9.
-
2004: Spiegel Asaf; Kollet Orit; Peled Amnon; Abel Loya; Nagler Arnon; Bielorai Bella; Rechavi Gideon; Vormoor Josef; Lapidot Tsvee
Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling.
Blood 2004;103(8):2900-7.
-
2004: Inbal Aida; Muszbek László; Lubetsky Aharon; Katona Eva; Levi Itai; Kárpáti Levente; Nagler Arnon
Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(3):249-53.
-
2004: Nagler Raphael M; Nagler Arnon
Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment.
The Israel Medical Association journal : IMAJ 2004;6(3):167-72.
-
2004: Hardan Izhar; Rothman Rachel; Gelibter Alain; Cohen Ninette; Shimoni Avichai; Sokolovsky Maya; Reichart Malka; Ishoev Galina; Amariglio Ninette; Rechavi Gideon; Nagler Arnon; Trakhtenbrot Luba
Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis.
Experimental hematology 2004;32(3):254-60.
-
2004: Bishara A; De Santis D; Witt C C; Brautbar C; Christiansen F T; Or R; Nagler A; Slavin S
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Tissue antigens 2004;63(3):204-11.
-
2004: Cohen Yossi; Nagler Arnon
Treatment of refractory autoimmune diseases with ablative immunotherapy.
Autoimmunity reviews 2004;3(2):21-9.
-
2004: Nagler R M; Nagler A
The molecular basis of salivary gland involvement in graft--vs.--host disease.
Journal of dental research 2004;83(2):98-103.
-
2004: Gnainsky Yulia; Spira Gadi; Paizi Melia; Bruck Rafael; Nagler Arnon; Abu-Amara Suha Naffar; Geiger Benjamin; Genina Olga; Monsonego-Ornan Efrat; Pines Mark
Halofuginone, an inhibitor of collagen synthesis by rat stellate cells, stimulates insulin-like growth factor binding protein-1 synthesis by hepatocytes.
Journal of hepatology 2004;40(2):269-77.
-
2004: Cohen Yossi; Nagler Arnon
Cord blood biology and transplantation.
The Israel Medical Association journal : IMAJ 2004;6(1):39-46.
-
2004: Nagler Arnon; Korenstein-Ilan Avital; Amiel Aliza; Avivi Lydia
Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells.
Experimental hematology 2004;32(1):122-30.
-
2004: Peled T; Mandel J; Goudsmid R N; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall E J; Nagler A
Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
Cytotherapy 2004;6(4):344-55.
-
2004: Samira Sarit; Ferrand Christophe; Peled Amnon; Nagler Arnon; Tovbin Yosef; Ben-Hur Herzl; Taylor Naomi; Globerson Amiela; Lapidot Tsvee
Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
Stem cells (Dayton, Ohio) 2004;22(6):1085-100.
-
2004: Shimoni Avichai; Nagler Arnon
Clinical implications of minimal residual disease monitoring for stem cell transplantation after reduced intensity and nonmyeloablative conditioning.
Acta haematologica 2004;112(1-2):93-104.
-
2003: Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
Differences between graft product and donor side effects following bone marrow or stem cell donation.
Bone marrow transplantation 2003;32(9):873-80.
-
2003: Gross David J; Reibstein Israel; Weiss Lola; Slavin Shimon; Dafni Hagit; Neeman Michal; Pines Mark; Nagler Arnon
Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3788-93.
-
2003: Beider Katia; Nagler Arnon; Wald Ori; Franitza Suzanna; Dagan-Berger Michal; Wald Hanna; Giladi Hilla; Brocke Stefan; Hanna Jacob; Mandelboim Ofer; Darash-Yahana Merav; Galun Eithan; Peled Amnon
Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice.
Blood 2003;102(6):1951-8.
-
2003: Cohena Yossi; Nagler Arnon
Hematopoietic stem-cell transplantation using umbilical-cord blood.
Leukemia & lymphoma 2003;44(8):1287-99.
-
2003: Ben-Abraham Ron; Paret Gideon; Cohen Rinat; Szold Oded; Cividalli Gabriel; Toren Amos; Nagler Arnon
Diffuse alveolar hemorrhage following allogeneic bone marrow transplantation in children.
Chest 2003;124(2):660-4.
-
2003: Nagler A; Ohana M; Alper R; Doviner V; Sherman Y; Rabbani E; Engelhardt D; Ilan Y
Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
Bone marrow transplantation 2003;32(4):363-9.
-
2003: Shimoni Avichai; Hardan Izhar; Avigdor Abraham; Yeshurun Moshe; Raanani Pia; Ben-Bassat Isaac; Nagler Arnon
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma.
British journal of haematology 2003;122(3):457-64.
-
2003: Pines Mark; Snyder David; Yarkoni Shai; Nagler Arnon
Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(7):417-25.
-
2003: Kollet Orit; Shivtiel Shoham; Chen Yuan-Qing; Suriawinata Jenny; Thung Swan N; Dabeva Mariana D; Kahn Joy; Spiegel Asaf; Dar Ayelet; Samira Sarit; Goichberg Polina; Kalinkovich Alexander; Arenzana-Seisdedos Fernando; Nagler Arnon; Hardan Izhar; Revel Michel; Shafritz David A; Lapidot Tsvee
HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver.
The Journal of clinical investigation 2003;112(2):160-9.
-
2003: Federico Massimo; Bellei Monica; Brice Pauline; Brugiatelli Maura; Nagler Arnon; Gisselbrecht Christian; Moretti Luciano; Colombat Philippe; Luminari Stefano; Fabbiano Francesco; Di Renzo Nicola; Goldstone Anthony; Carella Angelo Michele;
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2320-5.
-
2003: Rozovskaia T; Ravid-Amir O; Tillib S; Getz G; Feinstein E; Agrawal H; Nagler A; Rappaport E F; Issaeva I; Matsuo Y; Kees U R; Lapidot T; Lo Coco F; Foa R; Mazo A; Nakamura T; Croce C M; Cimino G; Domany E; Canaani E
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(13):7853-8.
-
2003: Shimoni Avichai; Bielorai Bella; Toren Amos; Hardan Izhar; Avigdor Abraham; Yeshurun Moshe; Ben-Bassat Isaac; Nagler Arnon
Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity.
Experimental hematology 2003;31(5):428-34.
-
2003: Paltiel O; Rubinstein C; Or R; Nagler A; Gordon L; Deutsch L; Polliack A; Naparstek E
Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma.
Bone marrow transplantation 2003;31(7):565-9.
-
2003: Trop Shivti; Nagler Arnon; Ilan Yaron
Role of NK1.1+ and AsGm-1+ cells in oral immunoregulation of experimental colitis.
Inflammatory bowel diseases 2003;9(2):75-86.
-
2003: Locatelli Franco; Rocha Vanderson; Reed William; Bernaudin Françoise; Ertem Mehmet; Grafakos Stelios; Brichard Benedicte; Li Xiaxin; Nagler Arnon; Giorgiani Giovanna; Haut Paul R; Brochstein Joel A; Nugent Diane J; Blatt Julie; Woodard Paul; Kurtzberg Joanne; Rubin Charles M; Miniero Roberto; Lutz Patrick; Raja Thirumalairaj; Roberts Irene; Will Andrew M; Yaniv Isaac; Vermylen Christiane; Tannoia Nunzia; Garnier Federico; Ionescu Irina; Walters Mark C; Lubin Bertram H; Gluckman Eliane;
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.
Blood 2003;101(6):2137-43.
-
2003: Piliponsky Adrian M; Gleich Gerald J; Nagler Arnon; Bar Ilan; Levi-Schaffer Francesca
Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor.
Blood 2003;101(5):1898-904.
-
2003: Shimoni A; Kröger N; Zander A R; Rowe J M; Hardan I; Avigdor A; Yeshurun M; Ben-Bassat I; Nagler A
Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(2):290-7.
-
2003: Or Reuven; Shapira Michael Y; Resnick Igor; Amar Avraham; Ackerstein Aliza; Samuel Simcha; Aker Memet; Naparstek Elizabeth; Nagler Arnon; Slavin Shimon
Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.
Blood 2003;101(2):441-5.
-
2003: Panigrahi Soumya; Das Mayukh; Stagler Dalia; Konstantini Shlomi; Gmori Moshe; Slavin Shimon; Nagler Arnon
Development of secondary anaplastic oligoastrocytoma after matched unrelated bone marrow transplantation in a child with acute myeloid leukemia.
Acta haematologica 2003;109(4):196-8.
-
2003: Cohen Yossi; Polliack Aaron; Nagler Arnon
Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support.
Current pharmaceutical design 2003;9(3):279-88.
-
2002: Arditti Fabian D; Greenberg Ron; Dekel Benjamin; Marcus Hadar; Nagler Arnon; Berrebi Alain; Skornick Yehuda; Reisner Yair
Human colon adenocarcinoma in the SCID/CB6 radiation chimera is susceptible to adoptive transfer of allogeneic human peripheral blood mononuclear cells.
Journal of hematotherapy & stem cell research 2002;11(6):883-93.
-
2002: Shapira Michael Y; Bloom Allan I; Or Reuven; Sasson Talia; Nagler Arnon; Resnick Igor B; Aker Memet; Zilberman Irina; Slavin Shimon; Verstanding Anthony
Intra-arterial catheter directed therapy for severe graft-versus-host disease.
British journal of haematology 2002;119(3):760-4.
-
2002: Seger Reinhard A; Gungor Tayfun; Belohradsky Bernd H; Blanche Stephane; Bordigoni Pierre; Di Bartolomeo Paolo; Flood Terence; Landais Paul; Müller Susanna; Ozsahin Hulya; Passwell Justen H; Porta Fulvio; Slavin Shimon; Wulffraat Nico; Zintl Felix; Nagler Arnon; Cant Andrew; Fischer Alain
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
Blood 2002;100(13):4344-50.
-
2002: Kröger Nicolaus; Sayer Herbert Gottfried; Schwerdtfeger Rainer; Kiehl Michael; Nagler Arnon; Renges Helmut; Zabelina Tatjana; Fehse Boris; Ayuk Francis; Wittkowsky Georg; Schmitz Norbert; Zander Axel Rolf
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
Blood 2002;100(12):3919-24.
-
2002: Cohen Yossi; Nagler Arnon
Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support.
The Israel Medical Association journal : IMAJ 2002;4(11 Suppl):865-7.
-
2002: Saah Daniel; Sichel Jean-Yves; Schwartz Allan; Nagler Arnon; Eliashar Ron
CT assessment of bone marrow transplant patients with rhinocerebral aspergillosis.
American journal of otolaryngology 2002;23(6):328-31.
-
2002: Kollet Orit; Petit Isabelle; Kahn Joy; Samira Sarit; Dar Ayelet; Peled Amnon; Deutsch Varda; Gunetti Monica; Piacibello Wanda; Nagler Arnon; Lapidot Tsvee
Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation.
Blood 2002;100(8):2778-86.
-
2002: Shimoni A; Nagler A; Kaplinsky C; Reichart M; Avigdor A; Hardan I; Yeshurun M; Daniely M; Zilberstein Y; Amariglio N; Brok-Simoni F; Rechavi G; Trakhtenbrot L
Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(8):1413-8; discussion 1419-22.
-
2002: Schmitz Norbert; Beksac Meral; Hasenclever Dirk; Bacigalupo Andrea; Ruutu Tapani; Nagler Arnon; Gluckman Eliane; Russell Nigel; Apperley Jane F; Gorin Norbert C; Szer Jeff; Bradstock Ken; Buzyn Agnes; Clark Peter; Borkett Keith; Gratwohl Alois;
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.
Blood 2002;100(3):761-7.
-
2002: Petit Isabelle; Szyper-Kravitz Martine; Nagler Arnon; Lahav Meir; Peled Amnon; Habler Liliana; Ponomaryov Tanya; Taichman Russell S; Arenzana-Seisdedos Fernando; Fujii Nobutaka; Sandbank Judith; Zipori Dov; Lapidot Tsvee
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
Nature immunology 2002;3(7):687-94.
-
2002: Smith S J; Piliponsky A M; Rosenhead F; Elchalal U; Nagler A; Levi-Schaffer F
Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(6):906-13.
-
2002: Gur Hilit; Krauthgamer Rita; Berrebi Alain; Klein Tirza; Nagler Arnon; Tabilio Antonio; Martelli Massimo F; Reisner Yair
Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells.
Blood 2002;99(11):4174-81.
-
2002: Rozenfeld-Granot Galit; Toren Amos; Amariglio Ninette; Nagler Arnon; Rosenthal Ester; Biniaminov Miriam; Brok-Simoni Frida; Rechavi Gideon
MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells.
Experimental hematology 2002;30(5):473-80.
-
2002: Gavish Zohar; Pinthus Jehonathan H; Barak Vivian; Ramon Jacob; Nagler Arnon; Eshhar Zelig; Pines Mark
Growth inhibition of prostate cancer xenografts by halofuginone.
The Prostate 2002;51(2):73-83.
-
2002: Shimoni Avichai; Nagler Arnon
Non-myeloablative stem-cell transplantation in the treatment of malignant and non-malignant disorders.
The Israel Medical Association journal : IMAJ 2002;4(4):272-9.
-
2002: Slavin Shimon; Nagler Arnon; Shapira Michael Y; Aker Mehmet; Gabriel Cividalli; Or Reuven
Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantation.
Journal of clinical immunology 2002;22(2):64-9.
-
2002: Peled Tony; Landau Efrat; Prus Eugenia; Treves Abraham J; Nagler Arnon; Fibach Eitan
Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells.
British journal of haematology 2002;116(3):655-61.
-
2002: Garbuzenko E; Nagler A; Pickholtz D; Gillery P; Reich R; Maquart F-X; Levi-Schaffer F
Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(2):237-46.
-
2002: Bitan Menachem; Polliack Aaron; Zecchina Gabriella; Nagler Arnon; Friedmann Yael; Nadav Liat; Deutsch Varda; Pecker Iris; Eldor Amiram; Vlodavsky Israel; Katz Ben-Zion
Heparanase expression in human leukemias is restricted to acute myeloid leukemias.
Experimental hematology 2002;30(1):34-41.
-
2002: Shargal Yaron; Viola Nicola; Nagler Arnon; Merin Gideon; Schmidt Annete; Buddecke Erick; Ben-Sasson Shmuel A; Vlodavsky Israel
Inhibition of anastomotic intimal hyperplasia by a synthetic nonsulphated heparin-mimicking compound.
Experimental and clinical cardiology 2002;7(2-3):73-9.
-
2002: Varadi Gabor; Svirsky On; Nagler Arnon
Successful major surgical recovery of a patient following haploidentical stem cell transplantation for chronic myeloid leukemia in blast crisis and aspergillosis.
Acta haematologica 2002;108(1):29-32.
-
2002: Shimoni Avichai; Nagler Arnon
Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.
Cancer treatment and research 2002;110():113-36.
-
2001: Shimoni A; Nagler A
Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(12):1967-75.
-
2001: Pines M; Domb A; Ohana M; Inbar J; Genina O; Alexiev R; Nagler A
Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone.
Biochemical pharmacology 2001;62(9):1221-7.
-
2001: Slavin S; Or R; Aker M; Shapira M Y; Panigrahi S; Symeonidis A; Cividalli G; Nagler A
Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals.
Cancer chemotherapy and pharmacology 2001;48 Suppl 1():S79-84.
-
2001: Morecki S; Gelfand Y; Nagler A; Or R; Naparstek E; Varadi G; Engelhard D; Akerstein A; Slavin S
Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.
Bone marrow transplantation 2001;28(3):243-9.
-
2001: Nagler R M; Nagler A
The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease.
Archives of oral biology 2001;46(8):689-95.
-
2001: Slavin S; Nagler A; Shapira M; Panigrahi S; Samuel S; Or A
Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases.
Critical reviews in oncology/hematology 2001;39(1-2):25-9.
-
2001: Slavin S; Nagler A; Aker M; Shapira M Y; Cividalli G; Or R
Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders.
Reviews in clinical and experimental hematology 2001;5(2):135-46.
-
2001: Nagler A; Menachem Y; Ilan Y
Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment.
Journal of hematotherapy & stem cell research 2001;10(3):411-7.
-
2001: Shalit I; Kletter Y; Halperin D; Waldman D; Vasserman E; Nagler A; Fabian I
Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia.
European journal of haematology 2001;66(5):287-96.
-
2001: Kollet O; Spiegel A; Peled A; Petit I; Byk T; Hershkoviz R; Guetta E; Barkai G; Nagler A; Lapidot T
Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.
Blood 2001;97(10):3283-91.
-
2001: Panigrahi S; Nagler A; Or R; Wolf D G; Slavin S; Shapira M Y
Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation.
Bone marrow transplantation 2001;27(6):659-61.
-
2001: Nagler A; Aker M; Or R; Naparstek E; Varadi G; Brautbar C; Slavin S
Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.
Experimental hematology 2001;29(3):362-70.
-
2001: Bruck R; Genina O; Aeed H; Alexiev R; Nagler A; Avni Y; Pines M
Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
Hepatology (Baltimore, Md.) 2001;33(2):379-86.
-
2001: Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
Bone marrow transplantation 2001;27(2):183-90.
-
2001: Condiotti R; Zakai Y B; Barak V; Nagler A
Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood.
Experimental hematology 2001;29(1):104-13.
-
2000: Ponomaryov T; Peled A; Petit I; Taichman R S; Habler L; Sandbank J; Arenzana-Seisdedos F; Magerus A; Caruz A; Fujii N; Nagler A; Lahav M; Szyper-Kravitz M; Zipori D; Lapidot T
Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.
The Journal of clinical investigation 2000;106(11):1331-9.
-
2000: Elkin M; Miao H Q; Nagler A; Aingorn E; Reich R; Hemo I; Dou H L; Pines M; Vlodavsky I
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(15):2477-85.
-
2000: Nagler A; Ackerstein A; Or R; Naparstek E; Slavin S
Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation.
Experimental hematology 2000;28(11):1225-31.
-
2000: Nagler A; Gofrit O; Ohana M; Pode D; Genina O; Pines M
The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model.
The Journal of urology 2000;164(5):1776-80.
-
2000: Toren A; Nagler A; Rozenfeld-Granot G; Levanon M; Davidson J; Bielorai B; Kaplinsky C; Meitar D; Mandel M; Ackerstein A; Ballin A; Attias D; Biniaminov M; Rosenthal E; Brok-Simoni F; Rechavi G; Kaufmann Y
Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma.
Transplantation 2000;70(7):1100-4.
-
2000: Kapelushnik J; Mandel H; Varadi G; Nagler A
Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2000;22(5):433-6.
-
2000: Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
Bone marrow transplantation 2000;26(6):633-8.
-
2000: Nagler A; Or R; Naparstek E; Varadi G; Slavin S
Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation.
Experimental hematology 2000;28(9):1096-104.
-
2000: Slavin S; Nagler A; Varadi G; Or R
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis.
Experimental hematology 2000;28(7):853-7.
-
2000: Kollet O; Moore J G; Aviram R; Ben-Hur H; Liu B L; Nagler A; Shultz L; Feldman M; Lapidot T
The plant lectin FRIL supports prolonged in vitro maintenance of quiescent human cord blood CD34(+)CD38(-/low)/SCID repopulating stem cells.
Experimental hematology 2000;28(6):726-36.
-
2000: Ilan Y; Gotsman I; Pines M; Beinart R; Zeira M; Ohana M; Rabbani E; Engelhardt D; Nagler A
Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model.
Blood 2000;95(11):3613-9.
-
2000: Peled A; Kollet O; Ponomaryov T; Petit I; Franitza S; Grabovsky V; Slav M M; Nagler A; Lider O; Alon R; Zipori D; Lapidot T
The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.
Blood 2000;95(11):3289-96.
-
2000: Tsafrir A; Brautbar C; Nagler A; Elchalal U; Miller K; Bishara A
Alloreactivity of umbilical cord blood mononuclear cells: specific hyporesponse to noninherited maternal antigens.
Human immunology 2000;61(6):548-54.
-
2000: Slavin S; Or R; Prighozina T; Gurevitch O; Aker M; Panighari S; Shapira M; Nagler A
Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.
Bone marrow transplantation 2000;25 Suppl 2():S54-7.
-
2000: Levy S; Nagler A; Okon S; Marmary Y
Parotid salivary gland dysfunction in chronic graft-versus-host disease (cGVHD): a longitudinal study in a mouse model.
Bone marrow transplantation 2000;25(10):1073-8.
-
2000: Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Bone marrow transplantation 2000;25(10):1021-8.
-
2000: Nagler A; Pines M; Abadi U; Pappo O; Zeira M; Rabbani E; Engelhardt D; Ohana M; Chowdhury N R; Chowdhury J R; Ilan Y
Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
Hepatology (Baltimore, Md.) 2000;31(3):641-8.
-
2000: Nagler A; Rabinowitz R; Rosengolts-Rat J; Condiotti R; Schlesinger M
Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT).
Journal of hematotherapy & stem cell research 2000;9(1):63-75.
-
2000: Elchalal U; Fasouliotis S J; Shtockheim D; Brautbar C; Schenker J G; Weinstein D; Nagler A
Postpartum umbilical cord blood collection for transplantation: a comparison of three methods.
American journal of obstetrics and gynecology 2000;182(1 Pt 1):227-32.
-
1999: Nagler R M; Nagler A
Major salivary gland involvement in graft-versus-host disease: considerations related to pathogenesis, the role of cytokines and therapy.
Cytokines, cellular & molecular therapy 1999;5(4):227-32.
-
1999: Nagler A; Pines M
Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis.
Transplantation 1999;68(11):1806-9.
-
1999: Baraz L; Kotler M; Condiotti R; Nagler A
Sensitization of resting T cells to autologous natural-killer-cell-mediated lysis by phytohemagglutinin.
Cancer immunology, immunotherapy : CII 1999;48(9):507-16.
-
1999: Witenberg B; Kletter Y; Kalir H H; Raviv Z; Fenig E; Nagler A; Halperin D; Fabian I
Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells.
Radiation research 1999;152(5):468-78.
-
1999: Abramovitch R; Dafni H; Neeman M; Nagler A; Pines M
Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis.
Neoplasia (New York, N.Y.) 1999;1(4):321-9.
-
1999: Rosales F; Naparstek E; Varadi G; Or R; Slavin S; Nagler A
The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia.
Leukemia research 1999;23(10):947-52.
-
1999: Bishara A; Brautbar C; Cohen I; Nagler A
Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome.
Human immunology 1999;60(9):833-9.
-
1999: Nagler A; Condiotti R; Rabinowitz R; Schlesinger M; Nguyen M; Terstappen L W
Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC).
Medical oncology (Northwood, London, England) 1999;16(3):177-87.
-
1999: Elkin M; Reich R; Nagler A; Aingorn E; Pines M; de-Groot N; Hochberg A; Vlodavsky I
Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):1982-8.
-
1999: Elkin M; Ariel I; Miao H Q; Nagler A; Pines M; de-Groot N; Hochberg A; Vlodavsky I
Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone.
Cancer research 1999;59(16):4111-8.
-
1999: Nagler A; Ackerstein A; Kapelushnik J; Or R; Naparstek E; Slavin S
Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease.
Bone marrow transplantation 1999;24(3):339-42.
-
1999: Levi-Schaffer F; Garbuzenko E; Rubin A; Reich R; Pickholz D; Gillery P; Emonard H; Nagler A; Maquart F A
Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).
Proceedings of the National Academy of Sciences of the United States of America 1999;96(17):9660-5.
-
1999: Kollet O; Aviram R; Chebath J; ben-Hur H; Nagler A; Shultz L; Revel M; Lapidot T
The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice.
Blood 1999;94(3):923-31.
-
1999: Baraz L; Khazanov E; Condiotti R; Kotler M; Nagler A
Natural killer (NK) cells prevent virus production in cell culture.
Bone marrow transplantation 1999;24(2):179-89.
-
1999: Naparstek E; Delukina M; Or R; Nagler A; Kapelushnik J; Varadi G; Strauss N; Cividalli G; Aker M; Brautbar C; Waldmann H; Hale G; Slavin S
Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
Experimental hematology 1999;27(7):1210-8.
-
1999: Varadi G; Or R; Kapelushnik J; Naparstek E; Nagler A; Brautbar C; Amar A; Kirschbaum M; Samuel S; Slavin S; Siegal T
Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma.
Leukemia & lymphoma 1999;34(1-2):185-90.
-
1999: Nagler R M; Sherman Y; Nagler A
Histopathological study of the human submandibular gland in graft versus host disease.
Journal of clinical pathology 1999;52(5):395-7.
-
1999: Nagler R M; Nagler A
Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study.
Bone marrow transplantation 1999;23(10):1007-11.
-
1999: Aker M; Varadi G; Slavin S; Nagler A
Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1999;21(3):237-9.
-
1999: Rosales F; Peylan-Ramu N; Cividalli G; Varadi G; Or R; Naparstek E; Slavin S; Nagler A
The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
Bone marrow transplantation 1999;23(9):861-5.
-
1999: Nagler A; Morecki S; Slavin S
The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.
Molecular biotechnology 1999;11(2):181-94.
-
1999: Nagler A; Genina O; Lavelin I; Ohana M; Pines M
Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model.
American journal of obstetrics and gynecology 1999;180(3 Pt 1):558-63.
-
1999: Toren A; Nagler A; Amariglio N; Neumann Y; Golan H; Bilori B; Kaplinsky C; Mandel M; Biniaminov M; Levanon M; Rosenthal E; Davidson J; Brok-Simoni F; Rechavi G
Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency.
Bone marrow transplantation 1999;23(4):405-8.
-
1999: Peled A; Petit I; Kollet O; Magid M; Ponomaryov T; Byk T; Nagler A; Ben-Hur H; Many A; Shultz L; Lider O; Alon R; Zipori D; Lapidot T
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.
Science (New York, N.Y.) 1999;283(5403):845-8.
-
1998: Pick M; Nagler A; Grisaru D; Eldor A; Deutsch V
Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure.
British journal of haematology 1998;103(3):639-50.
-
1998: Or R; Ackerstein A; Nagler A; Amar A; Naparstek E; Varadi G; Kapelushnik J; Samuel S; Pugatsch T; Brautbar C; Slavin S
Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(6):447-53.
-
1998: Saah D; Elidan J; Braverman I; Eliashar R; Sichel J Y; Nagler A
Rhinocerebral aspergillosis.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1998;119(5):554-5.
-
1998: Nagler A; Finlander R; Or R; Naparstek E; Varadi G; Slavin S
The role of thiotepa in autologous bone marrow transplantation for acute leukemia.
Leukemia research 1998;22(11):991-5.
-
1998: Nagler A; Bishara A; Brautbar C; Barak V
Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.
Cytokines, cellular & molecular therapy 1998;4(3):161-7.
-
1998: Morecki S; Nagler A; Zakay-Rones Z; Schlesinger M; Lubina-Salomon A; Pugatsch T; Moshel Y; Slavin S
Tumorigenicity and immunogenicity in a murine model of B-cell leukemia/lymphoma (BCL1).
Leukemia research 1998;22(9):831-5.
-
1998: Toren A; Nagler R; Nagler A
Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities.
Medical oncology (Northwood, London, England) 1998;15(2):113-8.
-
1998: Toren A; Rechavi G; Nagler A
Early fulminant leukaemia post autologous bone marrow transplantation in non-Hodgkin's lymphoma patients.
Medical oncology (Northwood, London, England) 1998;15(2):109-12.
-
1998: Nagler A; Condiotti R; Nabet C; Naparstek E; Or R; Samuel S; Slavin S
Selective CD4+ T-cell depletion does not prevent graft-versus-host disease.
Transplantation 1998;66(1):138-41.
-
1998: Condiotti R; Nagler A
Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Experimental hematology 1998;26(7):571-9.
-
1998: Morecki S; Lubina-Salomon A; Slavin S; Nagler A
Cytokine gene transduction into non-immunogeneic murine tumor cells.
Cytokines, cellular & molecular therapy 1998;4(2):87-94.
-
1998: Schmitz N; Bacigalupo A; Hasenclever D; Nagler A; Gluckman E; Clark P; Bourquelot P; Greinix H; Frickhofen N; Ringdén O; Zander A; Apperley J F; Gorin C; Borkett K; Schwab G; Goebel M; Russell N H; Gratwohl A
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21(10):995-1003.
-
1998: Kapelushnik J; Varadi G; Nagler A
Matched unrelated human umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1998;20(3):257-9.
-
1998: Nagler A; Rivkind A I; Raphael J; Levi-Schaffer F; Genina O; Lavelin I; Pines M
Halofuginone--an inhibitor of collagen type I synthesis--prevents postoperative formation of abdominal adhesions.
Annals of surgery 1998;227(4):575-82.
-
1998: Pines M; Nagler A
Halofuginone: a novel antifibrotic therapy.
General pharmacology 1998;30(4):445-50.
-
1998: Nagler A; Soni S; Samuel S; Or R
Engraftment following mitoxantrone (Mito) based conditioning for allogeneic bone marrow transplantation (allo-BMT).
Leukemia research 1998;22(3):209-13.
-
1998: Or R; Ackerstein A; Nagler A; Kapelushnik J; Naparstek E; Samuel S; Amar A; Bruatbar C; Slavin S
Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study.
Cytokines, cellular & molecular therapy 1998;4(1):1-6.
-
1998: Aker M; Kapelushnik J; Pugatsch T; Naparstek E; Ben-Neria S; Yehuda O; Amar A; Nagler A; Slavin S; Or R
Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1998;20(2):145-8.
-
1998: Slavin S; Nagler A; Naparstek E; Kapelushnik Y; Aker M; Cividalli G; Varadi G; Kirschbaum M; Ackerstein A; Samuel S; Amar A; Brautbar C; Ben-Tal O; Eldor A; Or R
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
Blood 1998;91(3):756-63.
-
1998: Varadi G; Ackerstein A; Ben-Neriah S; Nagler A
Adoptive cell-mediated immunotherapy with interleukin-2 (IL-2) for relapsing lymphoblastic crisis following mismatched unrelated bone marrow transplantation in a chronic myelogenous leukemia patient.
Bone marrow transplantation 1998;21(1):93-6.
-
1998: Nagler R M; Laufer D; Nagler A
Parotid gland dysfunction in a murine model of acute graft versus host disease [aGVHD].
Head & neck 1998;20(1):58-62.
-
1998: Nagler A; Ackerstein A; Ben-Shahar M; Or R; Naparstek E; Ben-Yosef R; Slavin S
Continuous interleukin-2 infusion combined with cyclophosphamide- based combination chemotherapy in the treatment of hemato-oncological malignancies. Results of a phase I-II study.
Acta haematologica 1998;100(2):63-8.
-
1998: Slavin S; Nagler A
Immunotherapy in conjunction with autologous and allogeneic blood or marrow transplantation in lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 1():S31-9.
-
1997: Kapelushnik J; Or R; Slavin S; Nagler A
A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia.
Bone marrow transplantation 1997;20(12):1109-10.
-
1997: Chebath J; Fischer D; Kumar A; Oh J W; Kolett O; Lapidot T; Fischer M; Rose-John S; Nagler A; Slavin S; Revel M
Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities.
European cytokine network 1997;8(4):359-65.
-
1997: Slavin S; Nagler A
Cytokine-mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of interleukin-2-induced immunomodulation in allogeneic transplants.
The cancer journal from Scientific American 1997;3 Suppl 1():S59-67.
-
1997: Nagler A; Katz A; Aingorn H; Miao H Q; Condiotti R; Genina O; Pines M; Vlodavsky I
Inhibition of glomerular mesangial cell proliferation and extracellular matrix deposition by halofuginone.
Kidney international 1997;52(6):1561-9.
-
1997: Toren A; Nagler A
Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantation.
Bone marrow transplantation 1997;20(9):805-7.
-
1997: Toren A; Einat M; Fabian I; Nagler A
Human umbilical cord blood myeloid progenitor cells are relatively chemoresistant: a potential model for autologous transplantations in HIV-infected newborns.
American journal of hematology 1997;56(3):161-7.
-
1997: Nagler A; Nagler R; Ackerstein A; Levi S; Marmary Y
Major salivary gland dysfunction in patients with hematological malignancies receiving interleukin-2-based immunotherapy post-autologous blood stem cell transplantation (ABSCT).
Bone marrow transplantation 1997;20(7):575-80.
-
1997: Nagler A; Condiotti R; Lubina A; Deutsch V R
Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells.
Bone marrow transplantation 1997;20(7):525-31.
-
1997: Toren A; Ilan Y; Or R; Kapelushnik J; Nagler A
Impaired liver function tests in patients treated with antithymocyte globulin: implication for liver transplantation.
Medical oncology (Northwood, London, England) 1997;14(3-4):125-9.
-
1997: Toren A; Barak V; Novick D; Nagler A
Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
Cytokines, cellular & molecular therapy 1997;3(3):153-8.
-
1997: Pines M; Knopov V; Genina O; Lavelin I; Nagler A
Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis.
Journal of hepatology 1997;27(2):391-8.
-
1997: Ben-Yosef R; Or R; Naparstek E; Kapelushnik J; Samuels S; Slavin S; Nagler A
Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patients.
American journal of clinical oncology 1997;20(4):419-23.
-
1997: Toren A; Or R; Ackerstein A; Nagler A
Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT).
Bone marrow transplantation 1997;20(1):67-9.
-
1997: Nagler A; Ackerstein A; Or R; Naparstek E; Slavin S
Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantation.
Blood 1997;89(11):3951-9.
-
1997: Morecki S; Gelfand Y; Levi S; Nagler A; Condiotti R; Nabet C; Ackerstein A; Slavin S
Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patients.
Journal of hematotherapy 1997;6(2):115-24.
-
1997: Bursztyn M; Zelig O; Or R; Nagler A
Isradipine for the prevention of cyclosporine-induced hpertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study.
Transplantation 1997;63(7):1034-6.
-
1997: Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
Experimental hematology 1997;25(3):238-45.
-
1997: Bishara A; Brautbar C; Nagler A
HLA and graft-versus-host disease: a population-based study of HLA phenotypes of Jewish and Arabic bone marrow transplanted patients in Israel.
Leukemia research 1997;21(2):111-8.
-
1997: Toren A; Gadish M; Fabian I; Nagler A
The putative role of arylsulfatase in interleukin-2-mediated cytotoxicity and interleukin-7-mediated bactericidal activity of natural killer cells.
Annals of hematology 1997;74(2):83-7.
-
1997: Nagler A; Miao H Q; Aingorn H; Pines M; Genina O; Vlodavsky I
Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(1):194-202.
-
1997: Varadi G; Lossos A; Nagler A
Intrathecal prophylaxis following autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Acta oncologica (Stockholm, Sweden) 1997;36(3):349-50.
-
1996: Toren A; Or R; Breuer R; Nagler A
Bronchiolitis obliterans presenting as subcutaneous emphysema and pneumomediastinum: a case report.
Medical oncology (Northwood, London, England) 1996;13(4):195-7.
-
1996: Kapelushnik J; Nagler A; Or R; Naparstek E; Ackerstein A; Samuel S; Morecki S; Nabet C; Slavin S
Activated allogeneic cell therapy (allo-ACT) for relapsed chronic myelogenous leukemia (CML) refractory to buffy coat transfusions post-allogeneic bone marrow transplantation.
Bone marrow transplantation 1996;18(6):1153-6.
-
1996: Ben-Yosef R; Braverman I; Saah D; Nagler R; Shohat S; Or R; Nagler A
Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL).
Bone marrow transplantation 1996;18(5):1017-9.
-
1996: Nagler A; Brautbar C; Slavin S; Bishara A
Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity.
Bone marrow transplantation 1996;18(5):891-7.
-
1996: Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
Bone marrow transplantation 1996;18(4):721-4.
-
1996: Condiotti R; Nagler A
Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity.
Bone marrow transplantation 1996;18(4):713-20.
-
1996: Nagler A; Firman N; Feferman R; Cotev S; Pines M; Shoshan S
Reduction in pulmonary fibrosis in vivo by halofuginone.
American journal of respiratory and critical care medicine 1996;154(4 Pt 1):1082-6.
-
1996: Halevy O; Nagler A; Levi-Schaffer F; Genina O; Pines M
Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone.
Biochemical pharmacology 1996;52(7):1057-63.
-
1996: Einat M; Nagler A; Amiel A; Fejgin M D; Rudi A; Kashman Y; Fabian I
Synergistic effects of interleukin-11 with other growth factors on the expansion of hematopoietic progenitors from normal individuals and chronic myeloid leukemia patients resistant to treatment with cytosine arabinoside or eilatin.
Leukemia research 1996;20(9):751-9.
-
1996: Nagler R M; Nagler A
Effects of ionizing irradiation and beta-adrenergic stimulation on gene expression pattern in rat submandibular glands.
Anticancer research 1996;16(5A):2749-56.
-
1996: Nagler A; Shur I; Barak V; Fabian I
Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation.
Leukemia research 1996;20(8):637-43.
-
1996: Nagler A; Ilan Y; Varadi G; Kapelushnik J; Or R
In vivo CAMPATH-1 followed by T cell-depleted bone marrow transplantation: a potential new mode of therapy for hepatitis-associated severe aplastic anemia (SAA).
Bone marrow transplantation 1996;18(2):475-8.
-
1996: Toren A; Nagler A
Solitary pulmonary cholesteroloma, multiple xanthelasmas and lipemia retinalis complicating hypercholesterolemia after bone marrow transplantation.
Bone marrow transplantation 1996;18(2):457-9.
-
1996: Kapelushnik J; Naparstek E; Nagler A; Filon D; Oppenheim A; Amar A; Aker M; Samuel S; Slavin S
Second transplantation using allogeneic peripheral blood stem cells in a beta-thalassaemia major patient featuring stable mixed chimaerism.
British journal of haematology 1996;94(2):285-7.
-
1996: Toren A; Ackerstein A; Gazit D; Or R; Raveh D; Kupolovicz U; Engelhard D; Nagler A
Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and alpha-interferon immunotherapy.
Bone marrow transplantation 1996;18(1):209-10.
-
1996: Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
Transplantation 1996;62(1):138-42.
-
1996: Yarkoni S; Lishner M; Tangi I; Nagler A; Lorberboum-Galski H
B-cell non-Hodgkin's lymphoma: evidence for the t (14;18) translocation in all hematopoietic cell lineages.
Journal of the National Cancer Institute 1996;88(14):973-9.
-
1996: Dann E J; Friedlander Y; Leitersdorf E; Nagler A
The modulation of plasma lipids and lipoproteins during bone marrow transplantation is unrelated to exogenously administered recombinant human granulocyte-monocyte colony-stimulating factor (rHu GM-CSF).
Medical oncology (Northwood, London, England) 1996;13(2):81-6.
-
1996: Kapelushnik J; Verstandig A; Or R; Meretyk S; Drakos P; Naparstek E; Nagler A
Hydronephrosis in children after bone marrow transplantation: case reports.
Bone marrow transplantation 1996;17(5):873-5.
-
1996: Toren A; Rechavi G; Nagler A
Minimal residual disease post-bone marrow transplantation for hemato-oncological diseases.
Stem cells (Dayton, Ohio) 1996;14(3):300-11.
-
1996: Slavin S; Naparstek E; Nagler A; Kapelushnik Y; Ackerstein A; Or R
Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT.
Blood 1996;87(9):4011-3.
-
1996: Nagler A; Goldenhersh M A; Levi-Schaffer F; Bystryn J C; Klaus S N
Total leucoderma: a rare manifestation of cutaneous chronic graft-versus-host disease.
The British journal of dermatology 1996;134(4):780-3.
-
1996: Or R; Nagler A; Shpilberg O; Elad S; Naparstek E; Kapelushnik J; Cass Y; Gillis S; Chetrit A; Slavin S; Eldor A
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients.
Transplantation 1996;61(7):1067-71.
-
1996: Deutsch V R; Eldor A; Olson T; Barak V; Pick M; Nagler A
Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis.
Medical oncology (Northwood, London, England) 1996;13(1):31-42.
-
1996: Slavin S; Naparstek E; Nagler A; Ackerstein A; Samuel S; Kapelushnik J; Brautbar C; Or R
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.
Blood 1996;87(6):2195-204.
-
1996: Nagler R; Marmary Y; Krausz Y; Chisin R; Markitziu A; Nagler A
Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD).
Bone marrow transplantation 1996;17(2):219-24.
-
1996: Engelhard D; Elishoov H; Strauss N; Naparstek E; Nagler A; Simhon A; Raveh D; Slavin S; Or R
Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study.
Transplantation 1996;61(3):430-4.
-
1996: Toren A; Or R; Kapelushnik J; Chividalli G; Aku M; Slavin S; Nagler A
Normalization of serum lactic dehydrogenase in beta-thalassemia patients following bone marrow transplantation.
American journal of hematology 1996;51(2):166-7.
-
1996: Condiotti R; Slavin S; Barak V; Nagler A
The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors.
Leukemia research 1996;20(1):57-63.
-
1996: Abeliovich D; Yehuda O; Nagler A; Lerer I; Ben-Neriah S; Amar A; Or R
Predominant 45,X,--Y karyotype in donor cells after allogeneic BMT: cytogenetic and molecular analysis.
Cancer genetics and cytogenetics 1996;86(1):1-7.
-
1996: Levi-Schaffer F; Nagler A; Slavin S; Knopov V; Pines M
Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone.
The Journal of investigative dermatology 1996;106(1):84-8.
-
1996: Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Clinical transplants 1996;():281-90.
-
1996: Nyska M; Nyska A; Rivlin E; Porat S; Pines M; Shoshan S; Nagler A
Topically applied halofuginone, an inhibitor of collagen type I transcription, reduces peritendinous fibrous adhesions following surgery.
Connective tissue research 1996;34(2):97-103.
-
1995: Varadi G; Elchalal U; Brautbar C; Nagler A
Human umbilical cord blood for hematopoietic progenitor cells transplantation.
Leukemia & lymphoma 1995;20(1-2):51-8.
-
1995: Varadi G; Or R; Rund D; Orbach H; Slavin S; Nagler A
Severe migratory polyarthritis following in vivo CAMPATH-1G.
Bone marrow transplantation 1995;16(6):843-5.
-
1995: Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
Experimental hematology 1995;23(14):1667-75.
-
1995: Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Experimental hematology 1995;23(14):1553-62.
-
1995: Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
Experimental hematology 1995;23(14):1439-44.
-
1995: Nagler A; Eldor A; Naparstek E; Mumcuoglu M; Slavin S; Deutsch V R
Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro.
Experimental hematology 1995;23(12):1268-74.
-
1995: Nagler A; Or R; Nisman B; Kalickman I; Slavin S; Barak V
Elevated inflammatory cytokine levels in bone marrow graft rejection.
Transplantation 1995;60(9):943-8.
-
1995: Nagler A; Deutsch V R; Varadi G; Pick M; Eldor A; Slavin S
Recombinant human interleukin-6 accelerates in-vitro megakaryocytopoiesis and platelet recovery post autologous peripheral blood stem cell transplantation.
Leukemia & lymphoma 1995;19(3-4):343-9.
-
1995: Engelhard D; Elishoov H; Or R; Naparstek E; Nagler A; Strauss N; Cividalli G; Aker M; Ramu N; Simhon A
Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study.
Bone marrow transplantation 1995;16(4):565-70.
-
1995: Kapelushnik J; Or R; Filon D; Nagler A; Cividalli G; Aker M; Naparstek E; Slavin S; Oppenheim A
Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation.
Blood 1995;86(8):3241-6.
-
1995: Varadi G; Lossos A; Or R; Kapelushnik J; Nagler A
Successful allogeneic bone marrow transplantation in a patient with ATRA-induced pseudotumor cerebri.
American journal of hematology 1995;50(2):147-8.
-
1995: Lossos I S; Breuer R; Or R; Strauss N; Elishoov H; Naparstek E; Aker M; Nagler A; Moses A E; Shapiro M
Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study.
Transplantation 1995;60(7):672-8.
-
1995: Mor S; Nagler A; Barak V; Handzel Z T; Geller-Bernstein C; Fabian I
Histamine enhances granulocyte-macrophage colony-stimulating factor and interleukin-6 production by human peripheral blood mononuclear cells.
Journal of leukocyte biology 1995;58(4):445-50.
-
1995: Toren A; Ackerstein A; Slavin S; Nagler A
Role of interleukin-2 in human hematological malignancies.
Medical oncology (Northwood, London, England) 1995;12(3):177-86.
-
1995: Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
Potent antileukemic activity of the novel agents norsegoline and dibezine.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(8):823-9.
-
1995: Varadi G; Elchalal U; Shushan A; Schenker J G; Nagler A
Umbilical cord blood for use in transplantation.
Obstetrical & gynecological survey 1995;50(8):611-7.
-
1995: Kapelushnik J; Or R; Delukina M; Nagler A; Livni N; Engelhard D
Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation.
Journal of pediatric gastroenterology and nutrition 1995;21(1):110-2.
-
1995: Delukina M; Kapelushnik Y; Or R; Naparstek E; Slavin S; Nagler A
Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP).
Medical oncology (Northwood, London, England) 1995;12(2):125-7.
-
1995: Berman E; Kapelushnik J; Sharon I; Or R; Atlan H; Nagler A
Assessment of proton magnetic resonance spectroscopy of blood serum as a diagnostic tool in bone marrow transplantation.
Medical oncology (Northwood, London, England) 1995;12(2):109-14.
-
1995: Kapelushnik J; Engelhard D; Mehta J; Or R; Brandstetter Y; Picard E; Cividalli G; Nagler A
Sequential respiratory syncytial virus and cytomegalovirus pneumonia following bone marrow transplantation.
Journal of medical virology 1995;46(2):169-71.
-
1995: Abeliovich D; Yehuda O; Krichevsky S; Nagler A; Ben-Neriah S; Werner M; Ludkovsky O; Ben-Yehuda D
Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia.
Cancer genetics and cytogenetics 1995;81(2):115-7.
-
1995: Nagler A; Segal V; Slavin S; Levi-Schaffer F
Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.
Clinical and experimental immunology 1995;100(3):529-35.
-
1995: Barak V; Levi-Schaffer F; Nisman B; Nagler A
Cytokine dysregulation in chronic graft versus host disease.
Leukemia & lymphoma 1995;17(1-2):169-73.
-
1995: Naparstek E; Or R; Nagler A; Cividalli G; Engelhard D; Aker M; Gimon Z; Manny N; Sacks T; Tochner Z
T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.
British journal of haematology 1995;89(3):506-15.
-
1995: Nagler A; Ilan Y; Adler R; Or R; Naparstek E; Shouval D; Slavin S
Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination.
Bone marrow transplantation 1995;15(3):475-8.
-
1995: Deutsch V R; Olson T A; Nagler A; Slavin S; Levine R F; Eldor A
The response of cord blood megakaryocyte progenitors to IL-3, IL-6 and aplastic canine serum varies with gestational age.
British journal of haematology 1995;89(1):8-16.
-
1994: Nagler A; Peacock M; Tantoco M; Lamons D; Okarma T B; Okrongly D A
Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection.
Experimental hematology 1994;22(12):1134-40.
-
1994: Nevo S; Drakos P; Goldenhersh M A; Zlotogorski A; Or R; Naparstek E; Nagler A
Generalized granuloma annulare post autologous bone marrow transplantation in a Hodgkin's disease patient.
Bone marrow transplantation 1994;14(4):631-3.
-
1994: Amiel A; Yarkoni S; Slavin S; Or R; Lorberboum-Galski H; Fejgin M; Nagler A
Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1994;76(1):59-64.
-
1994: Fabian I; Kravtsov V; Elis A; Gurevitch O; Ackerstein A; Slavin S; Nagler A
Eosinophils activation in post-autologous bone marrow transplanted patients treated with subcutaneous interleukin-2 and interferon-alpha 2A immunotherapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(8):1379-84.
-
1994: Ilan Y; Nagler A; Shouval D; Ackerstein A; Or R; Kapelushnik J; Adler R; Slavin S
Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors.
Clinical and experimental immunology 1994;97(2):299-302.
-
1994: Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(4):245-8.
-
1994: Bishara A; Brautbar C; Nagler A; Slavin S; Leshem B; Cohen I; Kedar E
Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation.
Transplantation 1994;57(10):1474-9.
-
1994: Nagler A; Ilan Y; Amiel A; Eid A; Tur-Kaspa R
Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization.
Transplantation 1994;57(10):1458-61.
-
1994: Schechter D; Drakos P; Nagler A
Underlying coronary artery disease and successful bone marrow transplantation: a case report.
Bone marrow transplantation 1994;13(5):665-6.
-
1994: Nagler A; Slavin S; Yarkoni S; Fejgin M; Amiel A
Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1994;73(2):130-3.
-
1994: Saah D; Drakos P E; Elidan J; Braverman I; Or R; Nagler A
Rhinocerebral aspergillosis in patients undergoing bone marrow transplantation.
The Annals of otology, rhinology, and laryngology 1994;103(4 Pt 1):306-10.
-
1994: Kletter Y; Singer A; Nagler A; Slavin S; Fabian I
Ciprofloxacin enhances hematopoiesis and the peritoneal neutrophil function in lethally irradiated, bone marrow-transplanted mice.
Experimental hematology 1994;22(4):360-5.
-
1994: Engelhard D; Nagler A; Singer R; Barak V
Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasias.
Leukemia & lymphoma 1994;12(3-4):273-80.
-
1994: Or R; Mehta J; Kapelushnik J; Aker M; Naparstek E; Nagler A; Cividalli G; Slavin S
Total lymphoid irradiation, anti-lymphocyte globulin and Campath 1-G for immunosuppression prior to bone marrow transplantation for aplastic anemia after repeated graft rejection.
Bone marrow transplantation 1994;13(1):97-9.
-
1994: Nagler A; Naparstek E; Engelhard D
Combined therapy of granulocyte transfusions, intravenous opsonins and antibiotics for gram-negative pneumonia in neutropenic cancer patients.
Acta haematologica 1994;91(1):42-5.
-
1994: Nagler A; Ackerstein A; Barak V; Slavin S
Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2a.
Journal of hematotherapy 1994;3(1):75-82.
-
1994: Nagler A; Elishoov H; Kapelushnik Y; Breuer R; Or R; Engelhard D
Cytomegalovirus pneumonia prior to engraftment following T-cell depleted bone marrow transplantation.
Medical oncology (Northwood, London, England) 1994;11(3-4):127-32.
-
1993: Fabian I; Flidel O; Gadish M; Kletter Y; Slavin S; Nagler A
Effects of CAMPATH-1 antibodies on the functional activity of monocytes and polymorphonuclear neutrophils.
Experimental hematology 1993;21(12):1522-7.
-
1993: Deutsch V R; Nagler A; Slavin S; Condiotti R; Levine R F; Eldor A
Effect of bone marrow T lymphocytes treated with CAMPATH 1G on megakaryocyte colony formation.
Experimental hematology 1993;21(11):1427-35.
-
1993: Drakos P E; Nagler A; Or R; Naparstek E; Kapelushnik J; Engelhard D; Rahav G; Ne'emean D; Slavin S
Invasive fungal sinusitis in patients undergoing bone marrow transplantation.
Bone marrow transplantation 1993;12(3):203-8.
-
1993: Drakos P; Uziely B; Nagler A; Gillis S; Eldor A
Successful administration of low molecular weight heparin in a patient with heparin-induced thrombocytopenia and coumarin-induced skin necrosis.
Haemostasis 1993;23(5):259-62.
-
1993: Ilan Y; Nagler A; Adler R; Naparstek E; Or R; Slavin S; Brautbar C; Shouval D
Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation.
Hepatology (Baltimore, Md.) 1993;18(2):246-52.
-
1993: Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Transplantation proceedings 1993;25(3):2375-6.
-
1993: Ilan Y; Nagler A; Adler R; Tur-Kaspa R; Slavin S; Shouval D
Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor.
Gastroenterology 1993;104(6):1818-21.
-
1993: Morecki S; Nagler A; Puyesky Y; Nabet C; Condiotti R; Pick M; Gan S; Slavin S
Effect of various cytokine combinations on induction of non-MHC-restricted cytotoxicity.
Lymphokine and cytokine research 1993;12(3):159-65.
-
1993: Klapholz L; Ackerstein A; Goldenhersh M A; Vardy D; Nagler A
Local cutaneous reaction induced by subcutaneous interleukin-2 and interferon alpha-2a immunotherapy following ABMT.
Bone marrow transplantation 1993;11(6):443-6.
-
1993: Drakos P; Weinberger M; Delukina M; Or R; Nagler A; Weinberg M [corrected to Weinberger M ]
Inappropriate antidiuretic hormone secretion (SIADH) preceding skin manifestations of disseminated varicella zoster virus infection post-BMT.
Bone marrow transplantation 1993;11(5):407-8.
-
1993: Engelhard D; Naparstek E; Or R; Nagler A; Jacobs J; Shahar M B; Hardan I; Baciu H; Raveh D; Slavin S
Ganciclovir for the treatment of disseminated CMV disease without pneumonia in allogeneic T-lymphocyte depleted bone marrow transplantation.
Leukemia & lymphoma 1993;10(1-2):143-6.
-
1993: Amiel A; Yarkoni S; Fejgin M; Gaber E; Nagler A; Manor Y; Lishner M
Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemia.
Cancer genetics and cytogenetics 1993;65(1):32-4.
-
1993: Engelhard D; Nagler A; Hardan I; Morag A; Aker M; Baciu H; Strauss N; Parag G; Naparstek E; Ravid Z
Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients.
Bone marrow transplantation 1993;11(1):1-5.
-
1993: Nagler A; Mumcuoglu M; Naparstek E; Or R; Gan S; Slavin S
Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth.
Leukemia research 1993;17(1):61-7.
-
1993: Slavin S; Weiss L; Ackerstein A; Vourka-Karussis U; Morecki S; Or R; Nagler A; Kapelushnik J; Delukina M; Drakos P
Prevention and treatment of relapse by bone marrow transplantation.
Bone marrow transplantation 1993;12 Suppl 3():S54-6.
-
1993: Nagler A; Peacock M; Tantoco M; Lamons D; Okarma T B; Okrongly D A
Separation of hematopoietic progenitor cells from human umbilical cord blood.
Journal of hematotherapy 1993;2(2):243-5.
-
1992: Slavin S; Or R; Kapelushnik Y; Drakos P; Ackerstein A; Vourka-Karussis U; Weiss L; Nagler A
Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 4():164-6.
-
1992: Samuel S; Nagler A; Or R; Slavin S
Effects of interleukin 2 on engraftment following autologous bone marrow transplantation (ABMT) in dogs.
Leukemia research 1992;16(10):967-72.
-
1992: Naparstek E; Hardan Y; Ben-Shahar M; Nagler A; Or R; Mumcuoglu M; Weiss L; Samuel S; Slavin S
Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Blood 1992;80(7):1673-8.
-
1992: Drakos P E; Nagler A; Or R; Gillis S; Slavin S; Eldor A
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation.
Cancer 1992;70(7):1895-8.
-
1992: Fabian I; Shapira E; Gadish M; Kletter Y; Nagler A; Flidel O; Slavin S
Effects of human interleukin 3, macrophage and granulocyte-macrophage colony-stimulating factor on monocyte function following autologous bone marrow transplantation.
Leukemia research 1992;16(6-7):703-9.
-
1992: Or R; Mehta J; Nagler A; Craciun I
Neutropenic enterocolitis associated with autologous bone marrow transplantation.
Bone marrow transplantation 1992;9(5):383-5.
-
1992: Nagler A; Pavel L; Naparstek E; Muggia-Sullam M; Slavin S
Typhlitis occurring in autologous bone marrow transplantation.
Bone marrow transplantation 1992;9(1):63-4.
-
1992: Slavin S; Ackerstein A; Weiss L; Nagler A; Or R; Naparstek E
Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokines.
Cancer investigation 1992;10(3):221-7.
-
1992: Schechter D; Nagler A; Ackerstein A; Nassar H; Admon D; Naparstek E; Rein A J
Recombinant interleukin-2 and interferon alpha immunotherapy following autologous bone marrow transplantation. A case report of cardiovascular toxicity with serial echocardiographic evaluation.
Cardiology 1992;80(3-4):168-71.
-
1992: Morecki S; Revel-Vilk S; Nabet C; Pick M; Ackerstein A; Nagler A; Naparstek E; Ben Shahar M; Slavin S
Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2.
Cancer immunology, immunotherapy : CII 1992;35(6):401-11.
-
1991: Slavin S; Ackerstein A; Vourka-Karussis U; Nagler A; Or R; Naparstek E; Weiss L
Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation.
Baillière's clinical haematology 1991;4(3):715-25.
-
1991: Gomez S; Nagler A; Naparstek E; Slavin S
Transient elevation of serum lactic dehydrogenase following autologous bone marrow transplantation.
Bone marrow transplantation 1991;7(6):487-8.
-
1991: Slavin S; Ackerstein A; Kedar E; Reich S; Gomez S; Naparstek E; Nagler A; Or R; Weiss L
Induction of cell-mediated IL-2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation.
Transplantation proceedings 1991;23(1 Pt 1):802-3.
-
1991: Gadish M; Kletter Y; Flidel O; Nagler A; Slavin S; Fabian I
Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation.
Leukemia research 1991;15(12):1175-82.
Sign-in to see more
